Sen­a­tors press De­part­ment of De­fense on over­re­liance on for­eign drug man­u­fac­tur­ers

A bi­par­ti­san group of sen­a­tors on Tues­day re­leased a let­ter sent to De­fense Sec­re­tary Lloyd Austin seek­ing to build pres­sure around im­prov­ing sup­ply chain se­cu­ri­ty to min­i­mize drug short­ages, par­tic­u­lar­ly for drugs sourced en­tire­ly from for­eign coun­tries like Chi­na.

A DOD re­port, re­leased along­side the let­ter, shows that 27% of the drugs on the FDA’s es­sen­tial med­i­cines list were cat­e­go­rized by the De­fense Lo­gis­tics Agency as “Very High Risk” be­cause they are ei­ther de­pen­dent on Chi­nese man­u­fac­tur­ers us­ing Chi­nese ac­tive in­gre­di­ents or drugs of un­known sources.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER